Vault-13

Copernicus Capital Management, LLC

SAN FRANCISCO, CA · CIK 1694620 · 13F filing filed 2021-11-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$8.3m reported value +30.3% vs Q2 2021
13positions
93.2%in top 10
10 new 2 added 1 reduced 8 sold out vs Q2 2021

Holdings, Q3 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PFIZER INC COM PFE PFE 30,000 $1.3m15.61% 15.61% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 30.0k
2 THERMO FISHER SCIENTIFIC INC COM TMO TMO 2,000 $1.1m13.83% 13.83% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 2.0k
3 TELADOC HEALTH INC COM TDOC TDOC 7,000 $888.0k10.75% 10.75% NewShares held: Q4 2020 1.9k, Q1 2021 1.5k, Q2 2021 0, Q3 2021 7.0k
4 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 11,000 $850.0k10.29% 10.29% NewShares held: Q4 2020 10.7k, Q1 2021 10.0k, Q2 2021 0, Q3 2021 11.0k
5 JOHNSON & JOHNSON COM JNJ JNJ 5,000 $808.0k9.78% 9.78% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 5.0k
6 FATE THERAPEUTICS INC COM FATE FATE 12,000 $711.0k8.60% 8.60% AddedShares held: Q4 2020 3.2k, Q1 2021 8.0k, Q2 2021 10.0k, Q3 2021 12.0k +2.0k +2,000 20.0%
7 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 6,000 $657.0k7.95% 7.95% AddedShares held: Q4 2020 0, Q1 2021 0, Q2 2021 5.0k, Q3 2021 6.0k +1.0k +1,000 20.0%
8 ARCUS BIOSCIENCES INC COM RCUS RCUS 17,000 $593.0k7.18% 7.18% ReducedShares held: Q4 2020 0, Q1 2021 10.0k, Q2 2021 20.0k, Q3 2021 17.0k -3.0k -3,000 -15.0%
9 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 15,000 $386.0k4.67% 4.67% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 15.0k
10 MEDTRONIC PLC SHS MDT MDT 3,000 $376.0k4.55% 4.55% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 3.0k
11 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 40,000 $335.0k4.05% 4.05% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 40.0k
12 IMMATICS N.V SHS IMTX IMTX 10,000 $130.0k1.57% 1.57% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 10.0k
13 AMICUS THERAPEUTICS INC COM FOLD FOLD 10,000 $96.0k1.16% 1.16% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 10.0k

Sold out since Q2 2021

SecurityTickerShares held beforeValue then
VERTEX PHARMACEUTICALS INC VRTX VRTX 9,000 $1.8m9.0k shares
ATARA BIOTHERAPEUTICS INC 50,000 $778.0k50.0k shares
ZENTALIS PHARMACEUTICALS INC ZNTL ZNTL 10,000 $532.0k10.0k shares
TCR2 THERAPEUTICS INC TCRR TCRR 30,000 $492.0k30.0k shares
ACCOLADE INC ACCD ACCD 7,000 $380.0k7.0k shares
JAZZ PHARMACEUTICALS PLC JAZZ JAZZ 2,000 $355.0k2.0k shares
GRITSTONE BIO INC GRTS GRTS 35,000 $320.0k35.0k shares
THE BEAUTY HEALTH COMPANY 10,000 $168.0k10.0k shares